Skip to main content
Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · IEX Real-Time Price · USD
0.793
-0.032 (-3.90%)
At close: May 17, 2024, 4:00 PM
0.800
+0.007 (0.90%)
After-hours: May 17, 2024, 6:57 PM EDT

Bolt Biotherapeutics Revenue

Bolt Biotherapeutics had revenue of $11.32M in the twelve months ending March 31, 2024, with 67.96% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $5.27M with 188.83% year-over-year growth. In the year 2023, Bolt Biotherapeutics had annual revenue of $7.88M with 37.48% growth.

Revenue (ttm)
$11.32M
Revenue Growth
+67.96%
P/S Ratio
2.69
Revenue / Employee
$113,240
Employees
100
Market Cap
30.42M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20237.88M2.15M37.48%
Dec 31, 20225.73M4.47M354.68%
Dec 31, 20211.26M1.03M445.45%
Dec 31, 2020231.00K16.00K7.44%
Dec 31, 2019215.00K--
Dec 31, 20180--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

BOLT News

More News